Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Insulin-like peptide 5 is released in response to bile acid in the rectum and is associated with diarrhoea severity in patients with bile acid diarrhoea.

Title: Insulin-like peptide 5 is released in response to bile acid in the rectum and is associated with diarrhoea severity in patients with bile acid diarrhoea.
Authors: Bannon, Christopher A; Walters, Julian RF; Wu, Tongzhi; Kay, Richard G; Punnoose, Austin; Spiller, Robin C; Wilson, Jonathan; Verdino, Petra; Barker, Peter; Burling, Keith; Horowitz, Michael; Rayner, Christopher K; Ford, Alexander C; Reimann, Frank; Gribble, Fiona M
Publisher Information: BMJ; Department of Clinical Biochemistry
Publication Year: 2026
Collection: Apollo - University of Cambridge Repository
Subject Terms: BILE ACID; COLORECTAL MOTILITY; DIARRHOEA; GUT HORMONES; IRRITABLE BOWEL SYNDROME; Humans; Diarrhea; Male; Female; Insulin; Adult; Bile Acids and Salts; Middle Aged; Rectum; Proteins; Taurocholic Acid; Severity of Illness Index
Description: BACKGROUND: Insulin-like peptide 5 (INSL5) is an enteroendocrine hormone expressed in distal colonic 'L cells'. Bile acid receptor agonists are known to stimulate INSL5 secretion in primary cell culture, and administration of an INSL5 analogue in animals promotes colonic motility. OBJECTIVE: This study used a new immunoassay to measure INSL5 in human blood samples, enabling assessment of whether rectal bile acids stimulate INSL5 release in humans and whether INSL5 levels are altered in patients with chronic diarrhoea. DESIGN: Serum/plasma samples from previously performed studies were used, including healthy volunteers (n=7) who received a rectal enema of taurocholic acid (TCA); fasting and post prandial samples from healthy volunteers (n=10); patients with bile acid diarrhoea (BAD) (n=19) or irritable bowel syndrome with diarrhoea (IBS-D) (n=8); and patients with IBS-D (n=64) treated with ondansetron or placebo. RESULTS: Rectal TCA but not a control enema promptly elevated plasma INSL5, with the increase in INSL5 correlating negatively with time to, and positively with desire to, defecate post enema. Healthy volunteers had low INSL5 levels (
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
Relation: https://www.repository.cam.ac.uk/handle/1810/387024; https://doi.org/10.17863/CAM.119969
DOI: 10.17863/CAM.119969
Availability: https://www.repository.cam.ac.uk/handle/1810/387024; https://doi.org/10.17863/CAM.119969
Rights: Attribution 4.0 International ; https://creativecommons.org/licenses/by/4.0/
Accession Number: edsbas.43C56C8A
Database: BASE